Opzelura - direct healthcare professional communication (DHPC)

ruxolitinib phosphate
DHPCHuman

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

Tietoja

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Asiakirjat

Direct healthcare professional communication (DHPC) : Opzelura 15 mg/g cream (ruxolitinib phosphate): Important information regarding presence of particles in Opzelura cream

English (EN) (107.17 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

Key facts

Medicine name
Opzelura
Active substance
ruxolitinib phosphate
Therapeutic area (MeSH)
Vitiligo
DHPC type
Quality defect
Human ATC codes
D11AH
Dissemination date

Share this page